Wei An

2.9k total citations
96 papers, 2.1k citations indexed

About

Wei An is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Wei An has authored 96 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 31 papers in Molecular Biology and 29 papers in Epidemiology. Recurrent topics in Wei An's work include Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (21 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Wei An is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (21 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Wei An collaborates with scholars based in China, United States and Poland. Wei An's co-authors include Qiwen Ben, Ping Xie, Ying Jiang, Jing Huang, Jie Gao, Ying Jiang, Zhaoshen Li, Yaozong Yuan, Quan Cai and Hao Yu and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Wei An

91 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei An China 27 773 629 612 530 336 96 2.1k
Chengwei Tang China 26 617 0.8× 883 1.4× 665 1.1× 535 1.0× 377 1.1× 161 2.2k
Yuzo Kodama Japan 21 616 0.8× 491 0.8× 371 0.6× 349 0.7× 351 1.0× 104 2.1k
Osama N. El‐Assal United States 26 811 1.0× 511 0.8× 681 1.1× 542 1.0× 889 2.6× 37 2.8k
Rebecca Schuster United States 29 1.1k 1.4× 526 0.8× 486 0.8× 263 0.5× 447 1.3× 84 2.5k
Bostjan Humar Switzerland 34 1.3k 1.6× 972 1.5× 565 0.9× 576 1.1× 622 1.9× 74 3.0k
Jian Dong China 26 939 1.2× 454 0.7× 265 0.4× 586 1.1× 220 0.7× 96 2.4k
Matthias Woenckhaus Germany 21 916 1.2× 336 0.5× 506 0.8× 323 0.6× 185 0.6× 43 2.3k
Yuko Akazawa Japan 25 538 0.7× 885 1.4× 804 1.3× 250 0.5× 261 0.8× 115 2.3k
Fredrik Rorsman Sweden 32 538 0.7× 508 0.8× 511 0.8× 379 0.7× 370 1.1× 91 3.2k
Kosuke Kaji Japan 27 786 1.0× 452 0.7× 1.1k 1.8× 272 0.5× 902 2.7× 126 2.5k

Countries citing papers authored by Wei An

Since Specialization
Citations

This map shows the geographic impact of Wei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei An more than expected).

Fields of papers citing papers by Wei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei An. The network helps show where Wei An may publish in the future.

Co-authorship network of co-authors of Wei An

This figure shows the co-authorship network connecting the top 25 collaborators of Wei An. A scholar is included among the top collaborators of Wei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei An. Wei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Min, Meng Wang, Yang Xu, et al.. (2025). Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clinical Radiology. 86. 106915–106915. 1 indexed citations
4.
Liao, Yangying, Xiaomin Jia, Yi Ren, et al.. (2021). Suppressive role of microRNA-130b-3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2-HO-1 pathway activation. Human Cell. 34(5). 1532–1544. 29 indexed citations
5.
Li, Wen, et al.. (2021). Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury. American Journal of Transplantation. 22(1). 130–143. 32 indexed citations
7.
Qu, Yi, Ying He, Yang� Yang, et al.. (2020). ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway. Journal of Cancer. 11(9). 2621–2631. 30 indexed citations
8.
Liu, Limin, Ping Xie, Wen Li, Yuan Wu, & Wei An. (2018). Augmenter of Liver Regeneration Protects against Ethanol-Induced Acute Liver Injury by Promoting Autophagy. American Journal Of Pathology. 189(3). 552–567. 24 indexed citations
9.
Wang, Jing, Ziwei Li, Xin Wang, et al.. (2018). Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(11). 3780–3791. 14 indexed citations
10.
Luo, Lei, Ping An, Sujun Zheng, et al.. (2018). Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study. Frontiers in Genetics. 9. 662–662. 15 indexed citations
11.
Zhu, Shuguang, Yang‐Yang Qian, Wei Zhou, et al.. (2017). The application value of magnetic-controlled capsule endoscopy for gastric diseases in physical examination of asymptomatic population. Zhonghua xiaohua neijing zazhi. 34(5). 309–313. 1 indexed citations
12.
Zhan, Yutao, Ping Xie, Dongnian Li, et al.. (2017). Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in mice. Experimental Cell Research. 355(1). 40–46. 11 indexed citations
13.
Zhu, Shuguang, Yang‐Yang Qian, Xin‐Ying Tang, et al.. (2017). Gastric preparation for magnetically controlled capsule endoscopy: A prospective, randomized single-blinded controlled trial. Digestive and Liver Disease. 50(1). 42–47. 26 indexed citations
14.
Gu, Yuanting, Shuguang Zhu, Han Du, et al.. (2016). The clinical application of magnetically guided capsule endoscopy to 500 cases of gastric examination. Zhonghua xiaohua neijing zazhi. 33(11). 778–783.
15.
Sun, Guangyong, et al.. (2014). Involvement of Hepatic Stimulator Substance in the Regulation of Hepatoblast Maturation into Hepatocytes In Vitro. Stem Cells and Development. 23(14). 1675–1687. 6 indexed citations
16.
Zhou, Lingyun, et al.. (2014). Monitoring of Intrasplenic Hepatocyte Transplantation for Acute-on-Chronic Liver Failure: A Prospective Five-Year Follow-Up Study. Transplantation Proceedings. 46(1). 192–198. 30 indexed citations
17.
18.
Shen, Hong, et al.. (2011). Body mass index and the risk and prognosis of acute pancreatitis. European Journal of Gastroenterology & Hepatology. 23(12). 1136–1143. 92 indexed citations
19.
Wu, Yuan, et al.. (2007). Transfection of hepatic stimulator substance gene desensitizes hepatoma cells to H2O2-induced cell apoptosis via preservation of mitochondria. Archives of Biochemistry and Biophysics. 464(1). 48–56. 25 indexed citations
20.
Li, Chen, et al.. (2003). Increased cellular proliferation and protection of recombined human hepatic stimulator substance. Chieh P'ou Hsueh Pao. 34(2). 155–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026